Hanesbrands Inc
HBI: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$17.20 | Qtwpwn | Qdcqjps |
Hanesbrands Earnings: Financial Health Improving Despite Dismal Sales; Shares Very Undervalued
Momentum remains elusive for narrow-moat Hanesbrands, which missed our fourth-quarter forecast and issued disappointing 2024 guidance. Shares fell about 12% on the report, and we expect to reduce our $18.80 fair value estimate by a high-single-digit percentage. Even so, we believe the company is making progress on its key initiatives, including product enhancements and reductions in debt, inventory, and costs, and rate shares as very undervalued.